This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Members voted 28 to 6 in favor of an amended version of House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”
Late last week, the Governor signed House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”
House lawmakers have overwhelmingly approved two bills to amend the state’s medical marijuana program in a manner that significantly expands patients’ access to cannabis products. The state’s medical cannabis program became operational last August.
The first legal psilocybin therapyprogram to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapyprogram. Oregon’s Psilocybin TherapyProgram: Advisory Board Hard at Work.
Researchers have steadily advanced the field of psychedelic-assisted therapy over the last decade or two. This passage also spurred the development of an eagerly anticipated psychedelic-assisted therapy industry, now ready to see its very first patients very soon. What Does the Colorado Law Legalize Specifically?
Currently, in the 10 states that have legalized adult use cannabis and the 33 states that have legalized medical marijuana programs, entrepreneurs and small businesses are unable to access the valuable programs and support of the Small Business Administration. Small Businesses in the Cannabis Industry.
On Sunday, legislators finalized HB 819 , which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.” John Bel Edwards.
Doug Burgum signed legislation on Wednesday amending and expanding the state’s nascent medical cannabis access program. Though approved by voters in November 2016, the state’s medical cannabis access program is not yet fully operational. Republican Gov.
New laws expanding the medical marijuana program in Louisiana went into effect on August 1. The state’s medical marijuana program has been criticized for being too limited and too restrictive since the program was established in 2016, but the three laws that went into effect on Saturday aim to improve the situation.
According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5 percent in 2016).” ” Public comments “are part of the public record and are subject to public disclosure.
Anyone who has paid any attention to the cannabis “wellness” industry in recent years — whether through state medical and recreational programs or the free-for-all national CBD market — will be familiar with cannabinoid-infused topicals marketed to treat minor aches and pains. 11,24 4102. Advances in skin & wound care vol.
Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.
This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines.
It expands the pool of patients eligible for cannabis therapy to include those diagnosed with post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy, among other newly specified conditions.
All of the state programs are independent and in various stages of maturity. Many are having serious difficulty calculating and covering annual expenses for marijuana therapy. Certain conditions require more cannabinoids than others. Are you paying too much for medical marijuana?
In a groundbreaking decision, Connecticut Expands Medical Marijuana Program to Include Autism (ASD). To its list of qualifying conditions for the state’s medical marijuana program. And offers hope to countless families seeking alternative therapies for managing autism symptoms. The inclusion of autism.
Last year we passed unanimously the historic Let Doctors Decide bill that expanded patient access to our medical cannabis program,” said Senator Dunnavant, a medical doctor from Henrico. “We Patient access is critical to the success of Virginia’s medical cannabis program,” said Jenn Michelle Pedini, executive director of Virginia NORML.
At the state level, Governor Jay Inslee of Washington launched a new program and began granting pardons to those with past criminal misdemeanor marijuana-related convictions on their record. Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse.
This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.
Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Last session, the measure was vetoed by Governor Brown. CA resident?
Denver, Colorado’s marijuana social use law is here to stay, as the city council voted this week to remove the “sunset” provision which made it a temporary four year program. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.
In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. The FDA refers to this program as the expanded access program on their website. Cannabinoid Therapies for Cancer Patients.
Senator Anna Wishart (D) has re-introduced legislation, LB 110, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis. Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. AK resident?
In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025. 310.299.1717 Office.
The measure would permit physicians to recommend cannabis therapy to those diagnosed with an autism spectrum disorder as well as opioid use disorder. House Bill 158 authorizes the recommendation of medical marijuana in treating certain neurodegenerative diseases and conditions. Update : SB 2543 was approved by the Senate on 3/3/20.
State officials tasked with overseeing Ohio’s medical marijuana program approved last week the addition of three health conditions that qualify a patient to use cannabis medicinally. Spasticity is a medical condition characterized by prolonged muscle contraction and abnormal muscle tightness.
According to NORML participants in the study were enrolled in Israel’s federal marijuana access program and were able to choose from four select strains of cannabis. Patients were most likely to eliminate their use of opioids, anxiolytics, and anti-depressants after initiating cannabis therapy.”
2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. A 2022 study of 1247 people using at-home ketamine-assisted therapy found that 62% of participants reported a 50%+ improvement in depressive symptoms. But this program offers more than just the ketamine itself.
Pennsylvania’s Medical Marijuana Program, or “The Compassionate Use of Medical Cannabis Act (SB3),” allows people with specific medical conditions to use and purchase medical marijuana without having to worry about legal consequences. Cancer, including remission therapy. Anxiety disorders. Crohn’s disease.
Also this week Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act, to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions. You can submit your own feedback here.
Louisiana has had a medical cannabis program for many years. However, for patients to qualify for access to medical cannabis, they must have received a diagnosis of at least one of the 14 qualifying conditions that were initially approved under the initial law. The Bill as Passed. Now that the bill has been signed, as of August 1 st.,
After a psilocybin treatment,(it’s like) you’re still in your car, in traffic, but you have the windows up; the air conditioning is on and it’s quiet. Health Canada says it has received 15 requests for the use of psilocybin or MDMA — a psychedelic drug with stimulant properties — since resuming the program.
The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).
In 2018, the first full year of operations for the retail medical marijuana program in Pennsylvania, patients spent more than $130 million on the herbal medication. Inspired by the successful first full year, officials plan to expand the program by licensing more physicians, producers and retail dispensaries. Costa wrote on Twitter.
France’s (experimental) medical cannabis program. In March, 2021, France launched a two-year experiment to gauge the effectiveness of a nationwide medical marijuana program and to prepare the ground for future distribution, according to the Health Ministry. Shutterstock. Some 170 hospitals will participate in the two-year experiment.
As a part of the Arizona Medical Marijuana Act, Marijuana in Arizona can be used to treat: “A chronic or debilitating disease, medical condition or the treatment that causes: Cachexia or wasting syndrome. States with Medical Marijuana Programs Fill Less Opioid Prescriptions. Marijuana is Already Being Used to Treat Pain in Arizona.
Governor Jared Polis (D) of Colorado signed legislation into law that allows physicians to recommend medical cannabis for any condition for which an opiate would otherwise be prescribed. Legislation is pending, Senate Bill 236, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.
At the state level this week, activists gathered in Denver in conjunction with Colorado and Denver NORML chapters to lobby their state lawmakers in favor of workplace drug testing reforms, social consumption, parental protections and expanding access to the state’s medical cannabis program. HI resident? HI resident? HI resident? NM resident?
Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions.
Last month, the Ohio Medical Board made a landmark in the state which approved Irritable Bowel Syndrome (IBS) as a qualifying condition for Ohio’s medical marijuana program. This medication slows down metabolism and the digestion of food in the intestines, reducing the frequency of bowel movements and improving stool conditions.
By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.
Rachel Levine today announced that effective July 20, anxiety disorders and Tourette syndrome will be approved serious medical conditions in the medical marijuana program based on the recommendation of the Medical Marijuana Advisory Board and a review of medical research on the use of marijuana to treat these conditions.
Always consult a physician before attempting psychedelic therapy. According to Dr. Maria Rahmandar , medical director of the substance use program at Lurie Children’s Hospital of Chicago, “The findings here are pretty consistent with what I see clinically. Cannabis and magic mushrooms for the win!
For medicinal marijuana laws across the United States, understanding the qualifying conditions for accessing medical cannabis is the first step. Understanding Qualifying Conditions for Medical Marijuana in Texas Texas defines qualifying conditions as medical ailments that warrant the use of medical marijuana for therapeutic purposes.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content